Lower incidence of plasma cell neoplasm is maintained in migrant Chinese to British Columbia: Findings from a 30-year survey

Leukemia and Lymphoma

Volumn 52, Issue 12, 2011, Pages 2316-2320

  Chan, Vicky ^a   Song, Kevin ^a,b   Mang, Oscar ^c   Ip, Dennis K M ^d   Au, Wing Y ^e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c Hong Kong Cancer Registry ^*  (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Chinese; Migrants; Myeloma incidence

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; CANADA; CANCER INCIDENCE; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HEALTH CARE SURVEY; HONG KONG; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PLASMACYTOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SEX RATIO;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BRITISH COLUMBIA; CHINA; DISEASE SUSCEPTIBILITY; FEMALE; HONG KONG; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, PLASMA CELL; TRANSIENTS AND MIGRANTS; YOUNG ADULT;

EID: 82255193015     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.601475     Document Type: Review

References (27)

1. Kyle RA, Rajkumar SV. Multiple myeloma. Blood 2008;111: 2962-2972.
2. Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 1994;137(2 Suppl.):S68-S97. (Pubitemid 24060247)
3. Landgren O, Rajkumar S V, Pfeifer RM, et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined signif cance among black and white women. Blood 2010;116:1056-1059.
4. Landgren O, Kyle RA, Hoppin JA, et al. Pesticide exposure and risk of monoclonal gammopathy of undetermined signif cance in the Agricultural Health Study. Blood 2009;113:6386-6391.
5. Landgren O, Kristinsson SY, Goldin LR, et al. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined signif cance in Sweden. Blood 2009;114:791-795.
6. Grosbois B, Jego P, Attal M, et al. Familial multiple myeloma: report of f fteen families. Br J Haematol 1999;105:768-770. (Pubitemid 29277038)
7. Purdue MP, Lan Q, Menashe I, et al. Variation in innate immunity genes and risk of multiple myeloma. Hematol Oncol 2011;29:42-46.
8. Grass S, Preuss KD, Ahlgrimm M, et al. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined signif cance: a case-control study. Lancet Oncol 2009;10:950-956.
9. IARC. Cancer incidence and mortality worldwide in 2008. GLOBOCAN. 2008. Available from: http://globocan.iarc.fr/
10. Landgren O, Weiss BM. Patterns of monoclonal gammopathy of undetermined signif cance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia 2009;10:1691-1697.
11. Au WY, Gascoyne RD, Gallagher RE, et al. Hodgkin's lymphoma in Chinese migrants to British Columbia: a 25-year survey. Ann Oncol 2004;15:626-630. (Pubitemid 38559600)
12. Au WY, Gascoyne RD, Klasa RD, et al. Incidence and spectrum of non-Hodgkin lymphoma in Chinese migrants to British Columbia. Br J Haematol 2005;128:792-796. (Pubitemid 40444871)
13. Choi B, Hanley A, Holowaty E, et al. Use of surnames to identify individuals of Chinese ancestry. Am J Epidemiol 1993;138:723-734. (Pubitemid 23339015)
14. Breslow N, Day N. Statistical methods in cancer research. Vol. II. Te design and analysis of cohort studies. Lyon: IARC; 1987.
15. Bray F, Guilloux A, Sankila R, et al. Practical implications of imposing a new world standard population. Cancer Causes Control 2002;13: 175-182. (Pubitemid 34229682)
16. Ahmad O, Boschi-Pinto C, Lopez AD, et al. Age standardization of rates: a new WHO standard. Geneva: WHO; 2001.
17. Fay MP, Feuer EJ. Conf dence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 1997;16: 791-801. (Pubitemid 27165684)
18. Grulich AE, Swerdlow AJ, Head J, et al. Cancer mortality in African and Caribbean migrants to England and Wales. Br J Cancer 1992;66: 905-911.
19. Schwartz KL, Kulwicki A, Weiss LK, et al. Cancer among Arab Americans in the metropolitan Detroit area. Ethn Dis 2004;14:141-146. (Pubitemid 38262757)
20. NCI. Surveillance, Epidemiology and End Results (SEER). 2010. Available from: http://seer.cancer.gov/
21. Gao Y T, Lu W, editors. Myeloma incidence in Urban Shanghai. In: Cancer incidence, mortality and survival rates in urban Shanghai (1973-2000). Shanghai: Second Military Medical University Press; 2006. pp. 57-68.
22. Hirabayashi Y, Katanoda K. Comparison of time trends in multiple myeloma incidence (1973-1997) in East Asia, Europe and United States, from Cancer Incidence in Five Continents, Vols IV-VIII. Jpn J Clin Oncol 2008;38:720-721.
23. Weiss BM, Abadie J, Verma P, et al. A monoclonal gammo-pathy precedes multiple myeloma in most patients. Blood 2009;113: 5418-5422.
24. Landgren O, Kyle RA, Pfeifer RM, et al. Monoclonal gammopathy of undetermined signif cance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009;113:5412-5417.
25. Bowden M, Crawford J, Cohen HJ, Noyama O. A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly. J Am Geriatr Soc 1993;41:11-14. (Pubitemid 23018043)
26. Landgren O, Gridley G, Turesson I, et al. Risk of monoclonal gammopathy of undetermined signif cance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 2006;107:904-906. (Pubitemid 43156286)
27. Fang J, Madhavan S, Alderman MH. Inf uence of nativity on cancer mortality among black New Yorkers. Cancer 1997;80:129-135. (Pubitemid 27270929)